Patent Number | Title | Applicant | Opposition Date |
---|---|---|---|
EP3574914 | Corticosteroid Compositions | MERITAGE PHARMA, INC. | Sep 1, 2022 |
EP2585075 | Methods Of Treatment For Esophageal Inflammation | MERITAGE PHARMA, INC. | May 4, 2022 |
EP2646003 | Rapidly Dispersing Granules, Orally Disintegrating Tablets And Methods | ADARE PHARMACEUTICALS, INC. | Feb 23, 2021 |
EP3354276 | Compositions For The Treatment Of Gastrointestinal Inflammation | MERITAGE PHARMA, INC. | Sep 23, 2020 |
EP3041476 | Corticosteroid Containing Orally Disintegrating Tablet Compositions For Eosinophilic Esophagitis | ADARE DEVELOPMENT I, L.P. | Jul 22, 2020 |
EP3403654 | Orally Administered Corticosteroid Compositions | ADARE DEVELOPMENT I, L.P. | Apr 28, 2020 |
EP2214679 | Corticosteroid Compositions | MERITAGE PHARMA, INC. | Dec 19, 2019 |
EP2482822 | Orally Administered Corticosteroid Compositions | ADARE DEVELOPMENT I, L.P. | Mar 1, 2019 |
EP2211896 | Compositions For The Treatment Of Gastrointestinal Inflammation | MERITAGE PHARMA, INC. | Sep 27, 2018 |
EP2214677 | Compositions For The Treatment Of Inflammation Of The Gastrointestinal Tract | MERITAGE PHARMA, INC. | May 22, 2018 |
Patent Number | Grant Date | Title | Total Oppositions |
---|---|---|---|
EP2886108 | Nov 2, 2022 | Optimised Pharmaceutical Formula For The Treatment Of Inflammatory Changes Of The Esophagus | 1 |
EP3086782 | Sep 26, 2018 | Optimized Pharmaceutical Formulation For The Treatment Of Inflammatory Conditions Of The Esophagus | 1 |
Feel free to send us a message here and we will get back to you